Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study
Modern Rheumatology · 2025
DOI: 10.1093/mr/roae066 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shuqin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Dermatomyositis, Hemoperfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objectives
Haemoperfusion (HP) is used to treat various diseases, including sepsis and acute respiratory distress syndrome. However, few studies have explored the efficiency of HP in dermatomyositis-associated acute exacerbation of interstitial lung disease.
Methods
We conducted a retrospective study. Two hundred and sixteen patients with dermatomyositis-associated acute exacerbation of interstitial lung disease were included. Patients were divided into the HP group (treatment group) and the control group. Changes in oxygenation, haemodynamic parameters, lung ultrasound scores, and inflammatory cytokine levels were evaluated before and after HP in the treatment group. The length of intensive care unit (ICU) stays, duration of ventilator therapy, mortality rate, and incidence of complications were compared between the treatment and control groups.
Results
Haemodynamic and oxygenation variables in the treatment group significantly improved after treatment. However, the levels of the inflammatory factors significantly decreased after treatment. The length of ICU stay and the duration of ventilator therapy were significantly shorter in the treatment group than in the control group. The mortality rate of the treatment group was significantly lower than that of the control group.
Conclusions
This study demonstrated that HP could improve treatment efficacy in patients with dermatomyositis-associated acute exacerbation of interstitial lung disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Critical Care Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Oral Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
Zitieren
APA
Sun, S., Yu, Y., Feng, W., Sun, L., & Yang, S. (2025). Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study. Modern Rheumatology. https://doi.org/10.1093/mr/roae066
Vancouver
Sun S, Yu Y, Feng W, Sun L, Yang S. Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study. Modern Rheumatology. 2025. doi:10.1093/mr/roae066
BibTeX
@article{Sun2025,
author = {Sun, Shuqin and Yu, Yanfei and Feng, Wenjing and Sun, Luyan and Yang, Shuo},
title = {Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roae066}
}
EUVIMED